Skip to main content
Premium Trial:

Request an Annual Quote

Five Japanese Pharmas License Ariadne's Pathway Software

NEW YORK (GenomeWeb News) - Ariadne said today it has recently licensed its Pathway Studio Enterprise software to five Japanese pharmaceutical companies through its distribution partner World Fusion.
 
The software is used to analyze data from microarray, proteomics, and other experiments and is supported by the company’s Resnet mammalian and plant databases.
 
Ariadne said World Fusion has been distributing its products in Japan since 2004.
 
Ariadne did not name the five pharmaceutical companies that have licensed its software.
 
Financial terms of the agreements were not released.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.